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Developmental biology has evolved from a descriptive science to one based on genetic principles and
molecular mechanisms. Although molecular biology and genetic technologies have been the primary drivers
of this transformation, synthetic strategies have been increasingly utilized to interrogate the mechanisms of
embryonic patterning with spatial and temporal precision. In this review, we survey how chemical tools and
engineered proteins have been used to perturb developmental processes at the DNA, RNA, protein, and
cellular levels. We discuss the design principles, experimental capabilities, and limitations of each method,
as well as future challenges for the chemical and developmental biology communities.The transformation of a single, totipotent cell into a multicellular
organism requires a complex ensemble of molecular programs
that are executed with spatiotemporal fidelity. Understanding
how these chemical mechanisms give rise to form and function
is a major objective of modern embryology, which has evolved
from a descriptive science based on tissue manipulations and
morphological observations to one that integrates genomic
technologies and quantitative, molecular models. For example,
vertebrate limb development along the proximal-distal axis
requires the ‘‘apical ectodermal ridge,’’ epithelial tissue overlying
the limb bud tip, and it is now known that fibroblast growth
factors (FGFs) expressed by these cells are key mediators of
this growth (Fallon et al., 1994; Niswander et al., 1993). Digit
identity is similarly dictated by a posterior ‘‘zone of polarizing
activity’’ that is now associated with limb bud cells that secrete
the morphogen Sonic Hedgehog (Shh) (Niswander et al., 1994),
and dorsal-ventral patterning of the limb is regulated by the
dorsal ectoderm, which produces another morphogen called
Wnt7a (Parr andMcMahon, 1995). Genetic analyses and compu-
tational models have further established that these signaling
pathways do not act independently; rather, they interact through
feedback mechanisms to coordinate vertebrate limb patterning
in space and time (Mackem and Lewandoski, 2009; Zeller
et al., 2009).
The integration of molecular principles into embryological
theory can be primarily attributed to advances in molecular
biology and genomic technologies. Mutagenesis screens of
model organisms such as worms (Caenorhabditis elegans), fruit
flies (Drosophila melanogaster), zebrafish (Danio rerio), and mice
(Musmusculus) have identified thousands of genetic loci that are
required for embryonic patterning, many of which have now
been mapped by positional cloning. Methods for targeted gene
disruption in whole organisms, such as knockouts generated
by homologous recombination or nonhomologous end joining,
have allowed biologists to study embryonic patterning genes
in a more deliberate manner, and collectively these studies
have revealed several evolutionarily conserved genes—FGFs,
Hedgehogs (Hhs), Wnts, bone morphogenetic proteins (BMPs),
Notch receptors, and their downstream effectors, to name590 Chemistry & Biology 17, June 25, 2010 ª2010 Elsevier Ltd All riga few—that are used iteratively and combinatorially to control
cell behavior and fate during embryogenesis. The completion
ofmultiple genome-sequencing efforts has further revolutionized
the study of organismal development by providing a comprehen-
sive list of patterning molecules and their cis-regulatory
elements, and whole-genome approaches are now commonly
applied in developmental biology research. These latter technol-
ogies include the use of DNA microarrays or massively parallel
sequencing to identify genes that are expressed in specific
embryonic contexts, as well as the coupling of these methods
with chromatin immunoprecipitation to uncover trans-regulatory
mechanisms. High-throughput strategies are also being used to
conduct genome-wide phenotypic screens in cell-basedmodels
and even whole organisms, typically through RNA interference
(RNAi) methods.
Although genetic methodologies have dominated develop-
mental biology for the past three decades, it has become
increasingly clear that further advances in the field will require
fresh ideas and new approaches. Like many biological disci-
plines, embryology is becoming a quantitative science that
strives to explain complex phenotypes in terms of molecular
components, thermodynamic equilibria, and kinetic rates (Lewis,
2008). In addition to the vertebrate limb development studies
described above, Drosophila body segmentation has been
predictively modeled according to the anterior-posterior distri-
bution of specific transcriptional activators and repressors and
their cooperative affinities for binding sites within segmentation
gene enhancers (Segal et al., 2008). Dorsal-ventral patterning
of the frog embryo (Xenopus laevis and X. tropicalis) has also
been quantitatively described as opposing concentration gradi-
ents of BMPs and their extracellular antagonists that are scaled
relative to embryo size through a molecular shuttling mechanism
(Ben-Zvi et al., 2008). Establishing, testing, and refining new
models will require an ability to perturb developmental signaling
mechanisms with a spatial and temporal precision that is difficult
to achieve through genetic manipulations alone. Conventional
knockout technologies have limited temporal control, RNAi
usually requires hours to sufficiently deplete targeted transcripts,
and posttranslational processes are inherently difficult to targethts reserved
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concepts and synthetic elements, however, are less constrained
by Nature’s molecular architecture. As a result, the develop-
mental biologist’s toolbox now includes a growing number of
chemistry-based technologies.
In this review, we provide an overview of how synthetic strat-
egies have been used to study embryonic development in
a variety of model organisms. We categorize these technologies
according to their mechanisms of action, including targeted
perturbations at the transcriptional, RNA, protein, and cellular
levels. The use of small-molecule modulators in developmental
biology has been reviewed elsewhere and will not be revisited
here (Firestone and Chen, 2010; Yeh and Crews, 2003). Rather,
we focus on rationally designed technologies, examine their
underlying chemical and biological principles, and consider
their advantages and limitations. We also discuss emerging
chemical approaches that have not yet been applied in model
organisms but could prove to be valuable tools for in vivo
studies. We hope that this review will not only provide its readers
with a synopsis of this nascent field but also inspire further explo-
ration of embryonic development through the lens of chemical
biology.
Chemical Control of Gene Transcription
Dynamic, stereotypic gene expression is a primary driver of
embryonic patterning, and developmental biologists have there-
fore focused on technologies that enable in vivo transcriptional
control. Commonly used gene inactivation strategies include
knockouts through homologous recombination (Mansour et al.,
1988), TILLING (targeting-induced local lesions in genomes)
(McCallum et al., 2000), and RNAi-dependent gene silencing
(Fire et al., 1998). The transcription of exogenous genes
throughout the organism or in a cell-specific manner can also be
readily achieved through the transient introduction or genomic
integration of oligonucleotide constructs. Although these
approaches have yielded key insights into the genetic programs
that give rise to tissue form, they are typically constitutive or
dependent on endogenous trans-regulatory mechanisms.
Genetic recombination technologies such as the Cre/loxP and
FLP/FRT systems can provide greater conditionality in some
cases (Dymecki, 1996; Gu et al., 1994), but even these methods
are constrained by the promoters used to activate Cre or FLP
recombinase expression. Small molecules, however, can alter
embryonic gene transcription with precise spatial, temporal,
and/or dose control. In particular, ligand-inducible transcription
factors and recombinases have been used to achieve transcrip-
tional regulation in vivo, combining the rapidity and tunability of
chemical modulation with the specificity of genetic targeting.
Small-Molecule-Dependent Transcription Factors
Like several chemical approaches, the development of synthetic
transcriptional activators that are light-actuated has been
largely inspired by Nature’s regulatory mechanisms. Signaling
proteins that mediate hormonal responses were first co-opted
as tools for transcriptional control, as it was found that the
ligand-binding domains of the glucocorticoid, estrogen, and
ecdysone receptors (GR, ER, and EcR) can be fused to heterol-
ogous proteins to modulate their function (Figure 1A) (Christo-
pherson et al., 1992; Eilers et al., 1989; Green and Chambon,
1987). As with endogenous hormone receptors, these chimericChemistry & Bitransactivators are complexed with cytosolic proteins such as
heat shock protein 90 (Hsp90), and ligand binding induces
a protein conformational change that disrupts this cytosolic
complex and allows the factor to translocate into the nucleus.
Coupling these ligand-binding domains to DNA-binding and
transactivating polypeptides therefore enables the small-
molecule-dependent transcription of genes driven by the corre-
sponding response elements.
Since their introduction during the late 1980s, chimeric
hormone receptors have been widely used to regulate gene
expression in cultured cells and embryos. For example, Kolm
and Sive fused the myogenic transcription factor MyoD to the
ligand-binding domains of either GR or ER, and frog embryos
expressing these chimeric transactivators exhibited ectopic
muscle cells upon treatment with dexamethasone or estradiol,
respectively (Kolm and Sive, 1995). The Zivkovic laboratory
generalized this approach by coupling the GR ligand-binding
domain to the DNA-binding and activation domains of the yeast
transcription factor Gal4, enabling the dexamethasone-depen-
dent expression of any UAS-driven transgene (de Graaf et al.,
1998). Using the Gal4-GR transactivator, they chemically
induced the expression of Xwnt1 and XactivinbB in zebrafish
embryos, resulting in morphological phenotypes associated
with the ectopic action of these morphogens. Due to potential
crosstalk between these transactivator systems and endoge-
nous GR or ER signaling, our laboratory subsequently developed
a ligand-gated transcription factor containing the EcR ligand-
binding domain, exploiting the orthogonality of this insect-
specific hormone receptor to vertebrate signaling mechanisms
(Esengil et al., 2007). By fusing this polypeptide to the Gal4
DNA-binding region and a minimal activation domain from
herpes simplex virus protein VP16 and expressing this transac-
tivator under the control of tissue-specific promoters, we were
able to achieve heart and skeletal muscle-specific green fluores-
cent protein (GFP) expression in zebrafish embryos upon expo-
sure to the synthetic EcR ligand tebufenozide.
The other commonly used technology for chemically inducible
gene expression takes advantage of the tetracycline resistance
mechanism in Escherichia coli (Thaker et al., 2010). Bacterial
resistance to this antibiotic involves the expression of a trans-
membrane efflux pump (TetA), which is regulated by a transcrip-
tional repressor (TetR). In the absence of tetracycline (or its
synthetic derivative doxycycline), TetR binds to operator
sequences (tetO) in the tetA regulatory domain; the binding of
tetracycline to TetR, however, promotes its dissociation from
tetO, enabling tetA transcription and antibiotic clearance from
the bacteria. Based on this system, Gossen and Bujard estab-
lished two ligand-inducible gene transcription strategies that
can be applied in mammals (Figure 1B). In the ‘‘Tet-Off’’ system,
the DNA- and ligand-binding domains of TetR are fused with the
VP16activation domain to formaconstitutive transcriptional acti-
vator (tTA) that is inhibited by tetracycline (Gossen and Bujard,
1992). The ‘‘Tet-On’’ system utilizes a ‘‘reverse’’ form of tTA
(rtTA) that actually requires tetracycline for tetO binding (Gossen
et al., 1995). Using these complementary methods, transgene
expression can be inhibited or activated in a ligand-dependent
manner, and it has been adapted for use in fruit flies (Bieschke
et al., 1998), zebrafish (Huang et al., 2005), frogs (Ridgway
et al., 2000), and mice (Furth et al., 1994; Kistner et al., 1996)ology 17, June 25, 2010 ª2010 Elsevier Ltd All rights reserved 591
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Reviewwith varying degrees of success. In oneparticularly elegant appli-
cation of this technology, the Tilghman laboratory studied the role
of endothelial receptor B (EDNRB) in murine embryogenesis
by integrating either tTA or rtTA into one Ednrb locus and tetO-
responsive elements into the other allele (Shin et al., 1999).
Administration of the tetracycline derivative doxycycline to
EdnrbtTA/EdnrbtetO or EdnrbrtTA/EdnrbtetO embryos therefore
suppressed or induced Ednrb transcription, respectively, while
maintaining the tissue specificity of the endogenous Ednrb
gene. By varying the timing of doxycycline treatment, Tilghman
and her coworkers were able to determine the developmental
stages duringwhich EDNRB signaling is required for the differen-
tiation of neural crest cells intomelanoblasts andenteric neurons.
Collectively, these examples demonstrate the temporal
control of embryonic transcription that can be achieved through
small-molecule ligands and synthetic receptors. They also illus-
trate the reliance of these systems on endogenous cis-regulatory
elements for spatial control. Whereas recapitulating native gene
expression patterns is adequate for certain applications,
promoter elements that will restrict transcription to targeted
cell populations are not always available, and in some cases it
would be advantageous to target tissues according to morpho-
logical cues alone. Synthetic chemistry has enabled develop-
mental biologists to circumvent these limitations. In particular,
the conjugation of caging groups to hormone or tetracycline
receptor ligands provides an extra level of conditionality that is
orthogonal to the timing of ligand addition and the spatiotem-
poral dynamics of transactivator expression. The precision of
optical techniques makes photoactivatable ligands especially
versatile reagents, and a number of light-activatable hormone
receptor ligands have been reported (Link et al., 2004, 2005).
Although the control of in vivo gene transcription with these
synthetic compounds has not yet been described, caged doxy-
cycline has been successfully used to induce embryonic gene
expression in a tissue-specific manner.
As a proof of principle, Cambridge and coworkers generated
transgenic mice that ubiquitously express an rtTA-based trans-
activator and carry a tetO-dependent GFP reporter (Cambridge
et al., 2009). Embryos surgically removed from these mice and
cultured with the 1-(4,5-dimethoxy-2-nitrophenyl)ethyl ether of
doxycycline (DMNPE-doxycycline) exhibited light-dependent
GFP expression that could be induced throughout the organism
or localized to a targeted area such as the dorsal root ganglia
(Figure 1C). Transgenic Xenopus tadpoles that expressed rtTA
and carried tetO-GFP reporter constructs responded to
DMNPE-caged doxycycline in a qualitatively similar manner,Figure 1. Synthetic Control of Gene Transcription
(A) Schematic representation of hormone receptor-based transactivator systems
factor; HR LBD, hormone receptor ligand-binding domain; HRE, hormone respo
(B) Schematic representation of tetracycline repressor-based transcription system
tetracycline and its synthetic derivatives are shown. Tet-R, Tet repressor; rTet-R,
Although hormone receptor- and tetracycline repressor-based transactivators can
schematic simplicity.
(C) Control of GFP expression in mice embryos using the Tet-On system and cage
shown. Adapted with permission (Cambridge et al., 2009; copyright 2009, Natur
(D) Schematic representation of tamoxifen-induced, Cre-dependent recombinati
depicted as a monomer for schematic simplicity, and chemical structures of tamo
domain.
(E) Tamoxifen-induced ‘‘self-knockout’’ of the Otx2 gene in mouse embryos u
observed only inOtx2flox/Cre-ERT2 embryos treated with the ER agonist. Adapted w
Organization).
Chemistry & Bisuggesting the generality of this approach. However, the lower
levels of GFP fluorescence observed in irradiated, DMNPE-
doxycycline-treated tadpoles in comparison to those treated
with unmodified doxycycline indicate that organismal pene-
trance of the caged ligand or its diffusion after photoactivation
may be limiting factors in some experimental contexts.
Small-Molecule-Dependent Recombinases
Although hormone receptor ligand-binding domains are used
endogenously to gate transcriptional activity, in principle they
could be used to control the function of any protein that acts
within the nucleus. Realizing this potential, the Chambon labora-
tory fused the bacteriophage P1 recombinase Cre to a mutated
ER ligand-binding domain that responds to the synthetic inducer
4-hydroxytamoxifen but not endogenous estrogens (Cre-ERT;
G525R human ER), thereby creating a small-molecule-depen-
dent genetic recombination system (Feil et al., 1996). Cells
expressing the Cre-ERT chimera will undergo 4-hydroxytamoxi-
fen-dependent excision or inversion of genomic DNA flanked by
loxP sites, depending on whether these 34 base pair regions
have the same or opposite orientations, respectively (Figure 1D).
McMahon and coworkers provided the first demonstration that
the Cre-ERT system can be used to effect genomic recombina-
tion in mouse embryos in utero, generating transgenic mice
with Wnt1 enhancer-dependent Cre-ERT expression and a
b-galactosidase reporter whose transcription requires the exci-
sion of the loxP site-flanked cassette (Danielian et al., 1998).
Injection of 4-hydroxytamoxifen into pregnant transgenic mice
induced Cre-mediated recombination and b-galactosidase
expression in the embryonic central nervous system which coin-
cides with the Wnt1 expression pattern.
The utility of this system for studying vertebrate development
has been further established by the Lamonerie laboratory (Fos-
sat et al., 2006). Mirroring Tilghman’s tTA/rtTA strategy for the
Ednrb gene, they generated transgenic mice in which one allele
of the Otx2 gene was replaced with cDNA encoding Cre-ERT2,
another 4-hydroxytamoxifen-specific inducible recombinase
(G400V/M543A/L544A mouse ER) (Feil et al., 1997). The other
Otx2 allele wasmodified to have unidirectional loxP sites flanking
the second exon (‘‘floxed’’ Otx2). One major advantage of this
‘‘self-knockout’’ approach is that the Cre-ERT2 transgene will
disrupt the remainingOtx2 allele only in cells that would normally
express this homeobox transcription factor at the time of 4-hy-
droxytamoxifen exposure; cells that would express Otx2 at later
developmental stages are spared. Accordingly, Otx2flox/Cre-ERT2
embryos in pregnant mice injected with tamoxifen prodrug
7.5 days postconception (E7.5) exhibited head phenotypes. Chemical structures for representative agonists are shown. TF, transcription
nse element.
s, including the ‘‘Tet-Off’’ and ‘‘Tet-On’’ configurations. Chemical structures of
reverse Tet transactivator; AD, activation domain; TetO, Tet repressor operon.
each form protein dimers, monomeric forms of these proteins are depicted for
d doxycycline. Both global and localized (dashed box and inset) irradiation are
e America, Inc.).
on, including excision and inversion reactions. The recombinase homodimer is
xifen and its derivatives are shown. ER LBD, estrogen receptor ligand-binding
sing the Cre-ERT2 system. Abnormal craniofacial and brain development is
ith permission (Fossat et al., 2006; copyright 2006, European Molecular Biology
ology 17, June 25, 2010 ª2010 Elsevier Ltd All rights reserved 593
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Reviewconsistent with a loss ofOtx2 function (Figure 1E). By varying the
timing of tamoxifen treatment, Lamonerie and coworkers were
able to determine that Otx2 is required for craniofacial develop-
ment before E10.5 and midbrain patterning between E10.5 and
E16.5. The Cre-ERT2/loxP system has also been validated in ze-
brafish embryos, and tamoxifen has been used to induce the
excision and inversion of transgenes in this model organism
(Hans et al., 2009).
In analogy to DMNPE-caged doxycycline, photoactivatable
versions of tamoxifen could broaden the utility of Cre-ERT2
as a tool for embryological research. Toward this goal, Jullien
and coworkers have synthesized and evaluated a number of
caged tamoxifen derivatives (Sinha et al., 2010). Because
ultraviolet light irradiation of 4-hydroxytamoxifen promotes its
photoisomerization and decomposition, they established that
4-hydroxycyclofen, a photostable structural analog, can interact
with the ERT2 ligand-binding domain with comparable potency
(Figure 1D). 4,5-dimethoxy-2-nitrobenzyl (DMNB)-caged 4-hy-
droxycyclofen can therefore convey light-dependent nuclear
translocation of proteins containing the ERT2 ligand-binding
domain, as demonstrated in cultured cells and zebrafish
embryos expressing a GFP-ERT2 chimera containing a nuclear
localization sequence. However, whether DMNB-4-hydroxycy-
clofen will be an effective reagent for light-controlled genomic
recombination in vivo remains uncertain. The success of this
approach will depend on how the kinetics of 4-hydroxycyclofen
efflux from irradiated cells compares to the rate of Cre-ERT2-
mediated DNA recombination. Consistent with this potential
limitation, Koh and coworkers have observed that even caged
4-hydroxytamoxifen derivatives that covalently modify the ER
ligand-binding domain cannot effectively induce Cre-ERT-medi-
ated recombination in cultured cells after photoactivation (Link
et al., 2005).
In principle, these approaches could also be applied to the
FLP/FRT recombination system, which has been widely used
in fruit flies and to a more limited extent in frogs, zebrafish, and
mice. The versatility of Cre/loxP-based technologies has also
been expanded with the development of heterologous loxP
sequences that efficiently recombine with themselves but not
the wild-type loxP site (Siegel et al., 2001). More sophisticated
genomic modifications can be achieved by combining these
orthogonal recombination platforms, including serial inversion
and excision steps to switch from the expression of one gene
to another (known as the FlEx switch method) (Schnutgen
et al., 2003). Nested, orthogonal recombination sites can also
be used to allow sequential inversion steps (Boniface et al.,
2009), potentially allowing genes to be switched on and off.
Combining these strategies with ligand-regulated recombinases
will allow developmental biologists to manipulate gene function
in vivo with improved dexterity.
Chemical Control of RNA Function
Although embryonic gene expression has been traditionally
studied at the transcriptional level, tissue patterning also involves
the regulation of RNA splicing, translation, and degradation. For
example, splice variants of DeltaC, a Notch receptor ligand,
have been found to have distinct signaling capabilities during
embryogenesis, differentially affecting midline development
and somitogenesis in zebrafish (Mara et al., 2008). Dozens of594 Chemistry & Biology 17, June 25, 2010 ª2010 Elsevier Ltd All rigmicroRNAs (miRNAs) are expressed in a stereotypic manner to
modulateRNA function in specific cell populations, and individual
miRNAs have been implicated in the specification of muscle,
lymphocytes, neurons, germ cells, and other cell types (Shi and
Jin, 2009). Chemical technologies that enable the targeting of
specific RNAs therefore constitute another effective means for
studying the molecular mechanisms of embryonic patterning.
One strategy has been to use ligand-inducible transcription to
control the expression of exogenous short hairpin RNAs
(shRNAs), which are processed by endogenous miRNA pathway
machinery into short interfering RNAs (siRNAs) and conse-
quently induce the degradation of targeted transcripts (Paddison
et al., 2002). The tamoxifen/Cre-ERT platform has been used to
selectively silence expression of the pluripotency factor Nanog
in primordial germ cells (Yamaguchi et al., 2009) and to knock
down FGF receptor 2 (Fgfr2) expression in the developing limb
(Coumoul et al., 2005). Reversible shRNA-mediated gene
silencing has been achieved in mice through the doxycycline/
Tet-on system (Seibler et al., 2007), and EcR-based transactiva-
tors have similarly been employed in cultured cells (Gupta et al.,
2004; Rangasamy et al., 2008). Because these methods are
straightforward applications of the transcriptional technologies
described above, we do not discuss them further here. Rather,
we highlight in this section approaches that utilize synthetic
chemistry to directly modulate RNA function in embryos. We
also discuss the application of ligand-gated riboswitches for
inducible gene expression in vivo.
Caged RNA Molecules
The microinjection of exogenous mRNAs and siRNAs into
embryos is a common technique for studying gene function,
especially at early developmental stages. In particular, mRNAs
are frequently injected into early-stage ascidian (Ciona intestina-
lis), sea urchin (Lytechinus variegatus and other species), zebra-
fish, and frog embryos to assess gain-of-function phenotypes,
and siRNAs are typically introduced into worms and fruit flies
to induce loss-of-function phenotypes. Although these methods
are simple and effective, their lack of conditionality limits their
utility for studying genes that have pleiotropic functions during
embryogenesis.
Because RNAs are not membrane permeable, introducing
mRNAs and siRNAs into embryos at later developmental time
points presents a major technical hurdle. Developmental and
chemical biologists have therefore pursued the caging of these
molecules with light-sensitive groups, as in principle these latent
RNAs could be microinjected at the one-cell stage and subse-
quently photoactivated in targeted cell populations. Blocking
RNA function through chemical modifications, however, is asso-
ciated with its own technical issues. For example, exogenous
mRNAs are typically generated by in vitro transcription, necessi-
tating the addition of caging groups to the full-length transcript
rather than in a site-specific manner.
The Okamoto group attempted to tackle this challenge by
reacting in vitro transcribed mRNAs with 6-bromo-4-diazo-
methyl-7-hydroxycoumarin (diazo-BHC), thereby modifying the
phosphodiester backbone with photocleavable groups (Fig-
ure 2A) (Ando et al., 2001). As a proof of principle, mRNAs
encoding GFP and b-galactosidase reporters were caged with
diazo-BHC and then injected into one-cell-stage zebrafish
embryos. Subsequent exposure of the embryos to 365 nm lighthts reserved
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(A) Chemical structures for natural oligonucleotides, their modified analogs, and nonnatural oligonucleotides. Caging groups are shown in red.
(B) Schematic representation of the caged MO hairpin (left) and PhotoMorph technologies (right).
(C) Light-controlled silencing of flh and heg in zebrafish embryos using caged MO hairpins. Adapted with permission (Ouyang et al., 2009; copyright 2009,
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Reviewinduced reporter expression as expected, yet the resulting levels
of GFP fluorescence or b-galactosidase activity were approxi-
mately one-eighth that achieved with the microinjection of
equivalent doses of unmodified mRNAs. In addition, the fold
change in reporter expression induced by photolysis was only
4- to 5-fold, a dynamic range that will be insufficient for many
experimental applications. This low efficacy undoubtedly
reflects the requirement of multiple caging groups to sufficiently
abrogate mRNA translation (approximately 30 modified phos-Chemistry & Biphodiesters per kilobase of RNA) and the low efficiency by which
they can all be removed. Another limiting factor is the chemical
instability of the caged mRNAs, as each BHC phosphotriester
is susceptible to intramolecular attack by the ribose 20-OH and
subsequent hydrolysis. Similar shortcomings were observed
by the Friedman group when they sought to cage siRNAs with
1-(1-diazoethyl)-4,5-dimethoxy-2-nitrobenzene (diazo-DMNB)
(Shah et al., 2005), indicating that these issues are inherent to
the general approach.ology 17, June 25, 2010 ª2010 Elsevier Ltd All rights reserved 595
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some possible ways forward. For example, siRNA analogs
composed of 20-deoxy-20-fluoro nucleic acids (siFNAs) still
promote the degradation of targeted transcripts, but their 20-flu-
oro modification renders them less susceptible to hydrolysis
(Figure 2A). siFNAs caged with diazo-DMNB consequently
exhibit greater stability in vivo, and Monroe and coworkers
have achieved light-inducible silencing of GFP expression in
zebrafish embryos using these reagents (Blidner et al., 2008).
The Friedman laboratory has recently reported an alternative
approach, in which the terminal phosphates of blunt-ended
siRNA precursors were selectively modified by diazo-DMNB
to yield stable caged duplexes (Figure 2A) (Shah et al., 2009).
Photoactivation of these oligonucleotides in cultured cells led
to a 6-fold decrease in gene expression, a dynamic range three
times greater than that observed for siRNAs with caged phos-
photriester linkages. Because siRNA- and siFNA-dependent
toxicity has been reported in zebrafish embryos, the promise
of these new synthetic oligonucleotides as functional genomic
tools may be best realized in worms, fruit flies, and other organ-
isms that are more tractable to RNAi.
Nonnatural, RNA-Targeting Oligonucleotides
Although RNAi is an effectivemethod for loss-of-function studies
in worms and fruit flies, it is less commonly used in other model
organisms such as zebrafish and frogs. In addition to their
possible cytotoxic effects, double-stranded RNAs have limited
perdurance in vivo, effectively restricting their application to
early developmental genes. Synthetic chemistry has yielded
nonnatural oligonucleotides that could potentially overcome
some of these limitations, including 20-OMe RNAs, phosphoro-
thioate (PS) DNAs, methoxyethylamine (MEA) and N,N-diethyle-
thylenediamine (DEED) phosphoramidates, locked nucleic acids
(LNAs), peptide nucleic acids (PNAs), morpholinos (MOs), and
chimeric oligomers composed of more than one nucleoside
class (Figure 2A). Each oligonucleotide utilizes standard DNA
bases while substituting the ribose backbone and/or phospho-
diester linkages with other chemical substituents, resulting in
enhanced in vivo stability. Depending on the specific structural
modifications, hybridization of the oligomers to their comple-
mentary RNA targets either promotes RNase H-dependent
transcript degradation or acts as a steric block at the site of
hybridization.
Although there have been a few reports of gene silencing in
frog embryos using PS DNAs (Woolf et al., 1990), MEA or
DEED phosphoramidate/DNA hybrids (Dagle et al., 1990, 2000;
Veenstra et al., 2000), and LNA/PS DNA chimeras (Lennox
et al., 2006), these RNase H-active antisense agents are not
widely used by the developmental biology community. Similarly,
PS DNAs and 20-OMe RNAs are not generally used to study
zebrafish embryogenesis, as they are both cytotoxic at doses
sufficient to alter RNA function (Tomasini et al., 2009). RNase
H-inactive antisense oligonucleotides such as MOs have proven
to be more effective reverse-genetic tools in vivo, and they have
been used to interrogate gene function in the embryos of
ascidians (Satou et al., 2001), sea urchins (Coffman et al.,
2004), zebrafish (Nasevicius and Ekker, 2000), frogs (Heasman
et al., 2000), chickens (Gallus gallus) (Kos et al., 2001), and
mice (Coonrod et al., 2001). These oligomers are composed of a
nuclease-resistant morpholino-phosphorodiamidate backbone,596 Chemistry & Biology 17, June 25, 2010 ª2010 Elsevier Ltd All rigand typically 25 base oligonucleotides are injected into embryos
at the one-cell stage, after which they can remain functional for
days (Nasevicius and Ekker, 2000; Summerton and Weller,
1997). MOs that hybridize to the start site or its flanking 50
untranslated region (UTR) can inhibit RNA translation, allowing
them to block bothmaternal and zygotic RNA function (Summer-
ton, 1999); those that target intron-exon junctions can yield
misspliced zygotic transcripts that include introns or skip exons,
frequently introducing a reading-frame shift and a premature
stop codon (Draper et al., 2001). MOs have also been used to
target miRNAs or their precursors to investigate the functions
of these noncoding RNAs (Flynt et al., 2007; Kloosterman
et al., 2007). In fact, thousands of MOs have been used to study
zebrafish development alone, targeting genes such as the
morphogen wnt8a, the Hh pathway component suppressor
of fused (sufu), and the mesodermal transcription factor no
tail-a (ntla).
PNAs also inhibit RNA function through RNase H-independent
steric blockade, but they have been applied in vivo to a much
lesser degree than MOs. This limited use is due in part to the
low water solubility of PNA oligomers, making it difficult to
achieve the micromolar concentrations required to block gene
expression in organisms. Farber and coworkers circumvented
this technical hurdle by utilizing negatively charged PNAs
(ncPNAs; also known commercially as gripNAs), which have a
backbonecomposedof trans-4-hydroxy-L-proline/phosphonate
polyamide subunits (Figure 2A) (Urtishak et al., 2003). ncPNAs
used for in vivo studies are typically shorter in length than MOs
(18 bases) because they hybridize to RNA with stronger affinity.
ncPNAs also exhibit greater sensitivity to base-pair mismatches
than MOs. In practice, both RNase H-inactive antisense oligonu-
cleotides can be effective gene-silencing tools in embryos, and in
some cases one reagent is more efficacious than the other even
when targeting the sameRNAsequence. For example, the Farber
laboratory observed that anncPNA targeting the homeoboxgene
dharma (dha) start site was able to recapitulate dha mutant
phenotypes, whereas an MO against the same region was inef-
fective. Yet only a handful of ncPNAs targeting embryonic tran-
scripts have been reported in the scientific literature, and all of
these genes are expressed early in development. It is therefore
possible that the amide bond-containing ncPNAs are more labile
in vivo than the phosphorodiamidate-based MOs.
MOs and ncPNAs do have certain limitations, however.
Although synthetic oligonucleotides have proven to be valuable
tools for studying developmental biology, phenotypes induced
by these reagents must be interpreted with caution. Both
reagents can have off-target effects that lead to embryonic
defects, including p53-dependent cell death. Appropriate
control experiments therefore must be conducted to confirm
the specificity of these antisense reagents in vivo, including reca-
pitulation of the phenotype with multiple MOs or ncPNAs against
the same gene and the use of base-pair-mismatch control oligo-
nucleotides (Eisen and Smith, 2008). The Farber and Ekker labs
have also demonstrated that MO and ncPNA off-target effects
can be minimized by concurrently inhibiting p53 expression
using a p53 MO, thereby unmasking the specific function of
the gene of interest (Robu et al., 2007).
In addition, the constitutive activities of conventional MOs and
ncPNAs render them less effective for studying genes that arehts reserved
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mental stages.Cagedantisenseoligonucleotides could therefore
bemore versatile probes of gene function, and those actuated by
light would be particularly useful in optically transparent embryos
such as those producedby ascidians, sea urchins, and zebrafish.
Toward this goal, our laboratory caged MOs by using a DMNB-
based photocleavable linker to tether the 25 base gene-targeting
oligonucleotide to a complementary inhibitor composed of MO
nucleosides (Figure 2B) (Shestopalov et al., 2007). Intramolecular
Watson-Crick base pairing produces an MO hairpin that cannot
effectively hybridize to its RNA target, and linker photolysis with
365 nm light liberates the targeting MO to allow RNA function
blockade. Using this approach, we have conditionally regulated
ntla expression in zebrafish embryos with spatial and temporal
precision, demonstrating that this T box family transcription
factor is required for notochord cell-fate commitment, migration,
and differentiation. We have also generated caged MOs against
several other developmental patterning genes, including floating
head (flh), heart of glass (heg), and ets variant gene 2 (etv2)
(Figure 2C) (Ouyang et al., 2009).
A similar ncPNA caging strategy was concurrently reported by
Dmochowski and coworkers, in this case using 18 base ncPNAs,
complementary 20-OMe RNA inhibitors, and a nitrobenzyl-based
linker (Tang et al., 2007). By microinjecting caged ncPNAs
targeting dha and the BMP antagonist chordin (chd) into zebra-
fish embryos and irradiating them globally with ultraviolet light,
they were able to induce mutant phenotypes. Interpreting these
developmental defects, however, is complicated by the release
of 20-OMe RNA upon linker photolysis, as these synthetic oligo-
nucleotides have been shown to be toxic to zebrafish embryos
(Tomasini et al., 2009).
More recently, the Mayer laboratory in collaboration with
SuperNova Life Sciences developed an alternative caging
strategy that employs MO/caged RNA duplexes called Photo-
Morphs (Figure 2B) (Tomasini et al., 2009). Like the caged MOs
and ncPNAs described above, these reagents utilize a single
light-sensitive group, in this case a nitrobenzyl-based linker
that joins two 12 base RNA oligonucleotides. The MO/caged
RNA duplex resists strand exchange with endogenous tran-
scripts, likely reflecting the fact that RNA-binding proteins and
RNA tertiary structure restrict the accessibility of the latter.
Photolysis of the caged RNA shifts the binding energetics in
favor of MO/mRNA hybridization, and PhotoMorphs have been
used to silence the expression of Ntla, E-cadherin, and Rheb in
zebrafish embryos. MO activity, however, is not fully restored
upon irradiation, as the caged RNA must be used in 5- to
10-fold molar excess to compensate for its gradual degradation
by endogenous nucleases. Unfortunately, other synthetic oligo-
nucleotides testedby theMayer laboratorywere found tobe toxic
to zebrafish embryos, preventing their use as caged inhibitors.
The PhotoMorph system is therefore conceptually similar to
havingmultiple caginggroupsperoligonucleotide;more thanone
caged RNA must be photolyzed to activate each MO molecule,
and the dynamic range of inducible activity is therefore limited.
Small-Molecule-Dependent Riboswitches
Whereas synthetic oligonucleotides and their caged derivatives
have proven to be valuable tools for the developmental biology
community, their versatility is offset by their irreversible activities.
ConventionalMOs and ncPNAs blockRNA function in a constitu-Chemistry & Bitive manner, and caged versions reported to date cannot be
turned off after they have been photoactivated. Because
embryogenesis utilizes a limited number of signaling molecules
in a dynamic, iterative manner, technologies that enable revers-
ible RNA control would advance our understanding of patterning
mechanisms. As with the hormone receptor family of transcrip-
tional modulators, Nature has provided us with examples for
how conditional RNA regulation can be achieved.
For instance, certain bacteria, fungi, and plant transcripts
contain cis-regulatory elements that respond to endogenous
metabolites, such as thiamine pyrophosphate, glycine, and
glucosamine-6-phosphate. Upon metabolite binding, these
RNAsequencesundergoconformational changes to adopt struc-
tures that either terminate transcription prematurely, prevent
ribosomal docking, or generate self-cleaving ribozymes. Such
mechanisms enable microbes and plants to modulate their
expression of biosynthetic enzymes in response to changes in
metabolite concentrations. The Mulligan laboratory pioneered
the use of riboswitches to control mammalian gene expression
by inserting a number of candidate ribozyme sequences into
various regions of a b-galactoside reporter gene (Yen et al.,
2004). Through this survey and subsequent optimization studies,
they determined that amutant formof the self-cleaving Sm1 ribo-
zyme from the trematode Shistosoma mansoni can prevent
reporter expression when inserted into the 50 UTR (Figure 2D).
By conducting a chemical library screen, they also discovered
that the nucleoside analog toyocamycin inhibits Sm1 self-
cleavage and rescues gene expression (Figure 2D) (Yen et al.,
2004, 2006). Toyocamycin-dependent RNA translation could be
achieved in both cultured cells and in mice infected with an ad-
eno-associatedvirus encodinga ribozyme-firefly luciferase trans-
gene, and in principle this technology could be used to control
embryonic gene expression. Subsequent studies by theMulligan
group revealed that inhibition of RNA self-cleavage by toyocamy-
cin actually requires its covalent incorporation into the transcript
itself rather than simply RNA/toyocamycin binding (Yen et al.,
2006). The kinetics by which transgene expression is lost upon
toyocamycin removal will consequently depend upon the degra-
dation rate of transcripts containing this nucleoside derivative. In
principle, greater temporal control could therefore be achieved
with small molecules that recapitulate the noncovalent modula-
tion of riboswitch function by endogenous metabolites.
Deiters and coworkers have extended the capabilities of this
approach by synthesizing a nitrobenzyl dioxolane derivative of
toyocamycin that liberates the nucleoside upon 365 nm light
exposure and intracellular hydrolysis (Figure 2D) (Young et al.,
2009). Thus, light-activated gene expression could be achieved
by combining these methodologies. It is also possible that
orthogonal small-molecule/riboswitch systems could be used
in parallel to independently control the expression of multiple
genes in a developing organism.
Chemical Control of Protein Function
Themajority of technologies described in the preceding sections
combine the specificity of genetically encoded components with
the rapid kinetics of small-molecule binding or photochemical
transformations. In most cases, however, the temporal precision
by which these systems can perturb embryonic gene function is
limited by endogenous processes. For techniques that activateology 17, June 25, 2010 ª2010 Elsevier Ltd All rights reserved 597
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Figure 3. Synthetic Control of Protein Function
(A) Schematic representation of rapamycin-induced polypeptide splicing using fusion proteins composed of FRB, FKBP, and split inteins.
(B) Schematic representation of ligand- and FKBP-dependent stabilization of FRB*-containing fusion proteins and the chemical structure of the FRB*-specific
rapamycin analog C20-MaRap. POI, protein of interest.
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transcription, RNA splicing or translation, or posttranslational
modifications required for protein function. Methods for inhibit-
ing oligonucleotide function are contingent on RNA and/or
protein degradation rates. Technologies that act directly on
signaling proteins could modulate patterning mechanisms with
greater speed, in principle enabling the study of developmental
processes that occur on the minute timescale. Indeed, the wide-
spread application of small molecules that selectively target Hh,
Wnt, BMP, or Notch pathway components exemplifies the
power of this approach. Because implementing small-molecule
modulators in a genome-wide manner has certain technical
challenges—the serendipitous nature of compound discovery
and the difficulty of establishing target specificity—we focus
here on strategies for protein regulation that are potentially
generalizable. Current technologies can be grouped into two
categories: (1) methods controlling protein splicing or stability;
and (2) those that are designed to regulate individual members
of specific protein families.
Small-Molecule-Dependent Protein Splicing
Rather than regulating protein function at the translational level,
an alternative strategy would be to induce the assembly of active
proteins from latent polypeptides. One mechanism that Nature
has evolved for posttranslational protein engineering is the use
of intein domains that catalyze their self-excision from polypep-
tide precursors and the simultaneous ligation of flanking
sequences (exteins) (Paulus, 2000). Most endogenous inteins
mediate cis-splicing within single-chain polypeptides, but at
least one intein subfamily that can couple two protein domains
in trans has been discovered (Wu et al., 1998). In the latter reac-
tion, the intein domain is split into two inactive fragments, each of
which is linked to a portion of another protein. Reconstitution of
the intein domain leads to its activation and trans-splicing of the
tethered polypeptide chains.
These remarkable reactions have prompted chemical biolo-
gists to create synthetic congeners that enable small-molecule
control of protein maturation. For example, the Muir laboratory
developed an artificial split-intein system by separating the
cis-splicing VMA intein of Saccharomyces cerevisiae into two
halvesandcoupling themto individual, complementary fragments
of a heterologous protein (Figure 3A) (Mootz andMuir, 2002). One
split-intein fusion protein was then tagged with FK506-binding
protein 12 (FKBP12) and the other with the FKBP12/rapamycin-
binding domain of mammalian TOR (FRB). Coexpression of the
split-intein system in cells and treatment with rapamycin lead to
formationof theFKBP12/rapamycin/FRBcomplex, reconstitution
of the VMA intein, and trans-splicing of the heterologouspolypep-
tides. Using this technology, Muir and coworkers have achieved
rapamycin-inducedsplicingof inactive firefly luciferase fragments
in fruit flies, which can be tuned by varying the rapamycin dose or
coadministering the FKBP12 ligand ascomycin to competitively(C) Rapamycin-dependent rescue of GSK3b activity in homozygous GSK3b-FR
during the two day drug regimen, but the majority of GSK3b-FRB*mice are fully r
Partial rescues were also observed (data not shown). Adapted with permission (
(D) Schematic representation of ligand-dependent stabilization of FKBP mutant-
(E) Schematic representation of the ‘‘bump-and-hole’’ strategy for achieving tar
promiscuous (PP1) and mutant kinase-specific (naphthylmethyl-PP1) inhibitors a
(F) Schematic representation of light-regulated protein conformation and functio
mononucleotide-based approaches are shown, with the azobenzene-linked sma
Chemistry & Biinhibit FKBP12/rapamycin/FRB complex formation (Schwartz
et al., 2007). In principle, this approach could be broadly applied
to study embryonic patterning mechanisms through the use of
rapamycin analog/FRB mutant pairs that are orthogonal to
endogenous signaling proteins (see below).
Liu and coworkers have reported a complementarymethod for
conditional protein splicing that involves insertion of the ER
ligand-binding domain into the RecA intein fromMycobacterium
tuberculosis (Buskirk et al., 2004). By subjecting this synthetic
construct to several cycles of mutagenesis and selection, they
identified chimeric inteins that can mediate cis-splicing of flank-
ing polypeptides in a 4-hydroxytamoxifen-dependent manner.
The technology was subsequently used to regulate the Gli family
of Hh pathway transcription factors in cultured cells (Yuen et al.,
2006). Although the 4-hydroxytamoxifen-induced splicing prod-
ucts could generate only about one-third of the Gli transcrip-
tional response observed with wild-type Gli1, this level of effi-
cacy was sufficient to differentiate pluripotent mesenchymal
cells into osteoblasts. Whether the intein-ER system in its current
form will be applicable in vivo awaits further study.
Small-Molecule-Dependent Protein Degradation
Rapamycin-mediated heterodimerization of FKBP12- and FRB-
tagged proteins has also been exploited to attain conditional
protein degradation. For instance, the Muir laboratory has devel-
oped a methodology that utilizes split ubiquitin for the rescue of
function (SURF), in which the protein of interest is fused to a de-
gron via the FRB domain and half of the ubiquitin polypeptide
(Pratt et al., 2007). The targeted protein is therefore constitutively
degradedby theproteosome, butwhen coexpressed in cellswith
another chimera composed of FKBP12 and the other half of ubiq-
uitin, it is stabilized in a rapamycin-dependent manner. This is
because the reconstituted ubiquitin that forms upon rapamycin
binding is cleaved from theprotein of interest by dedicated prote-
ases, taking the degron along with it. The FKBP12/rapamycin/
FRB system can be co-opted to achieve small-molecule-induc-
ible protein degradation as well, as demonstrated by Church
and coworkers (Janse et al., 2004). In this case, the
S. cerevisiae proteasome subunits Rpn10 or Pre10 were fused
to the yeast ortholog of FKBP12, and the protein of interest was
tagged with the yeast equivalent of the FRB domain. Rapamycin
treatment of yeast expressing these chimeras then leads to the
recruitment of the targeted protein to the proteosome, which is
sufficient to promote its degradation. Finally, the Kanemaki labo-
ratory has successfully transferred the auxin-based degron
system from plants to multiple animal cell lines, allowing proteins
tagged with auxin-induced degrons to be rapidly proteolyzed in
a small-molecule-dependent manner (Nishimura et al., 2009).
Although these systems can regulate protein degradation in
cultured cells, their efficacy in vivo has not yet been established.
To date, only two technologies for small-molecule-dependent
protein stability have been validated in whole organisms, andB* knock-in mouse embryos. Rapamycin has no effect on wild-type embryos
escued from cleft palate defects (white arrowhead) upon rapamycin treatment.
Liu et al., 2007; copyright 2007, Nature Publishing Group).
containing fusion proteins and the chemical structure of Shield-1.
geted protein inhibition with genome-wide specificity. Chemical structures of
re shown.
n using synthetic and endogenous cofactors. Azobenzene-, retinal-, and flavin
ll-molecule modulator depicted as a solid black circle.
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emerged serendipitously from collaborative efforts by the Crab-
tree and Wandless laboratories to develop rapamycin analog/
FRB mutant pairs that would avoid crosstalk with endogenous
TOR signaling (Stankunas et al., 2003). During the course of
these studies, they observed that proteins fused to one FRB
mutant containing three amino acid substitutions (FRB*;
K2095P/T2098L/W2101F human TOR) were rapidly degraded
by the proteosome, presumably because thesemutations desta-
bilize the FRB fold and consequently the entire chimeric protein.
The addition of rapamycin or its C20-methyallyl derivative
(MaRap) stabilized these fusion proteins by recruiting endoge-
nous FKBP12 (Figure 3B).
The Crabtree and Longaker laboratories then generated
mouse embryos homozygous for a glycogen synthase kinase
3b (GSK3b)-FRB* transgene knocked into the endogenous
GSK3b locus (Liu et al., 2007). In the absence of rapamycin,
these transgenic embryos phenocopied conventional GSK3b
knockouts, exhibiting cleft palates and skeletal defects.
Because rapamycin is teratogenic when administered to preg-
nant mice bearing wild-type embryos prior to the E10.5 stage
but does not cause overt developmental abnormalities at later
time points, they explored the phenotypic consequences of
48 hr drug treatments starting at E13.5. Through this temporal
analysis, it was determined that GSK3b is required between
E13.5 and E15 for palatogenesis and between E15.5 and E17
for skeletal development (Figure 3C). Unfortunately, effective
doses of the nonteratogenic compound MaRap could not be
achieved in utero, so using this methodology to investigate
protein functions at earlier developmental stages will require
new rapamycin analog/FRB mutant pairs.
The Wandless laboratory has further simplified this approach
by creating a new small-molecule-sensitive destabilization
domain that does not require formation of a ternary complex
(Banaszynski et al., 2006). In this ‘‘single-ligand, single-domain’’
system, a mutant, unstable form of human FKBP12 (F36V) is
fused to proteins of interest, promoting their degradation in an
FKBP12 ligand-dependent manner (Figure 3D). The availability
of nonteratogenic FKBP12 ligands such as Shield-1 and the
lack of endogenous binding partners help ensure that this
method can be applied to whole organisms with uniform efficacy
between cell types. Indeed, preliminary studies indicate that the
Shield-1/FKBP12 mutant technology can be used to condition-
ally and reversibly control protein levels in zebrafish embryos
without collateral developmental defects (T.J. Wandless, per-
sonal communication).
Small-Molecule-Based Targeting of Kinases
One drawback of chemically modulated protein homeostasis is
that functional perturbation of the targeted gene is not coincident
with ligand binding; rather, synthesis or degradation of the
mature protein is the rate-determining step. Direct activation or
inhibition of protein function by small molecules can occur on
faster timescales, but only a fraction of gene products have
known chemical regulators. Nevertheless, certain gene families
can now be systematically targeted by chemical inhibitors
through structure-based protein engineering and ligand design.
This strategy is exemplified by the Shokat laboratory’s develop-
ment of kinase mutant-targeted inhibitors that achieve genome-
wide specificity. By changing a large conserved residue in the600 Chemistry & Biology 17, June 25, 2010 ª2010 Elsevier Ltd All rigATP binding site (typically isoleucine, threonine, or phenylala-
nine) to either glycine or alanine, a ‘‘hole’’ can be introduced
into the kinase without significantly altering its catalytic activity.
Shokat and coworkers then designed kinase inhibitors with
a complementary ‘‘bump’’ by adding naphthyl or naphthylmethyl
groups to the Src family kinase inhibitor PP1 (Bishop et al., 1998).
Kinasemutants with these holes can be inhibited by these bump-
containing PP1 analogs, whereas wild-type kinase activities are
left intact (Figure 3E). Using this approach, individual tyrosine or
serine/threonine kinases can be specifically and reversibly in-
hibited in whole organisms, even those that have closely related
homologs. For example, Ginty and coworkers studied individual
members of the Trk receptor kinase family which respond to neu-
rotrophins to regulate nervous system development (Chen et al.,
2005). They knocked in naphthylmethyl-PP1-sensitive forms of
each Trk receptor (TrkAF592A, TrkBF616A, and TrkCF617A) into the
corresponding wild-type allele, and treated homozygous mutant
mouse embryos in utero with the PP1 derivative. Drug treatment
of the TrkAF592A, TrkBF616A, and TrkCF617A embryos led to loss of
superior cervical ganglia, nodose ganglia, and parvalbumin-
positive dorsal root ganglia neurons, respectively. The homozy-
gous mutants developed normally, and wild-type embryos were
insensitive to naphthylmethyl-PP1 treatment.
Optogenetic Control of Ion Channels
In most cases, small molecules can be used to modulate gene
function on physiologically relevant timescales. However, certain
biological processes such as neuronal depolarization occur
within milliseconds, and faster-acting technologies are neces-
sary to study these systems. Modulating ion channel function
during embryogenesis is an area of particular interest, as it is
nowwidely appreciated that electrical activity influencesmultiple
stages of neuronal development (Spitzer, 2006). Several
synthetic strategies for controlling neuronal action potentials
have beendeveloped and applied inwhole organisms, permitting
theactivation of specific neuronswithmillisecondprecision. All of
these methods involve light-gated channels that contain either
synthetic or endogenous photoisomerizable cofactors. Although
the application of these tools to investigate embryonic patterning
has not yet been reported, the examples below illustrate their
basic design principles and their utility for in vivo studies.
The use of synthetic photoswitchable compounds tomodulate
ion channel activity state dates back nearly four decades, when
Erlanger and coworkers found that electrophilic, azobenzene-
containing quaternary amines were able to alkylate the nicotinic
acetylcholine receptor (nAChR) and render it light-sensitive (Bar-
tels et al., 1971). The trans isomer of the azobenzene-containing
agonist locked the channel in an open state, and formation of
the cis isomer upon exposure to 330 nm light caused channel
inactivation (Figure 3F). Since this seminal work, several labora-
tories have applied this general strategy to other ion channels,
including ligand-gated, voltage-gated, and mechanosensitive
proteins. For example, the Trauner and Isacoff laboratories
engineered an ionotropic glutamate receptor (iGluR6) to incorpo-
rate a modifiable cysteine proximal to the glutamate binding site
(Volgraf et al., 2006). They then covalently attached a tether
agonist composed of maleimide, azobenzene, and glutamate
groups (MAG-1) to the iGluR6 mutant. The resulting synthetic
receptor rendered cells permeable to ion currents in a light-
dependent manner; irradiation with 380 nm light promoted cishts reserved
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nm light favored the trans-MAG-1 isomer and ion channel
closure. Photoswitching of the light-gated iGluR6 receptor
(LiGluR6) occurred on the millisecond timescale, and the degree
of channel activation could bemodulated by changing the wave-
length of light.
Even though the MAG-1/LiGluR6 technology requires channel
adduct formation with an electrophilic reagent, Trauner and
Isacoff have successfully used this approach to explore neuronal
function in whole organisms (Wyart et al., 2009). They created
a zebrafish line containing a UAS-dependent LiGluR6 transgene
and then crossed it with several transgenic lines expressing Gal4
in different subsets of spinal neurons. The progeny were then
treated with MAG-1 and stimulated with pulses of 390 nm light
to depolarize the targeted cells, resulting in neuron-specific
behaviors. For example, light activation of caudal Kolmer-
Agduhr neurons induced tail oscillations that mimicked forward
swimming, whereas bilateral illumination of caudal Rohon-Beard
neurons induced tail bends characteristic of the touch-escape
response.
Light-gated channels found in Nature have been more widely
applied to interrogate neuronal function, owing to their reliance
on endogenous retinal as a cofactor rather than reactive syn-
thetic ligands (Figure 3F) (Zhang et al., 2007a). Although several
photoresponsive channels have been identified, channelrhodop-
sin-2 (ChR2) from the green algae Chlamydomonas reinhardtii
and halorhodopsin from the halobacterium Natronomonas
pharaonis (NpHR) are the two most commonly used proteins
(Lanyi et al., 1990; Nagel et al., 2003). ChR2 is cation channel
that allows Na+ ions to enter the cell in response to 470 nm light,
and NpHR is a chloride pump that is activated by 580 nm light.
Neuronal firing can therefore be induced and suppressed by
ChR2 and NpHR, respectively, permitting the generation of
specific action potential profiles with millisecond resolution.
These light-gated channels have been used to modulate neuron
function in worms (Nagel et al., 2005; Zhang et al., 2007b), fruit
flies (Schroll et al., 2006), zebrafish (Baier and Scott, 2009; Dou-
glass et al., 2008), mice (Bi et al., 2006; Zhang et al., 2007b), and
even primates (Han et al., 2009), demonstrating their efficacy
across neuronal subtypes and animal species. The Deisseroth
laboratory’s development of photoactivatable rhodopsin-G-
protein-coupled receptor chimeras that actuate intracellular
signaling pathways promises to extend this approach to other
developmental processes (Airan et al., 2009).
Optogenetic Control of Small GTPases
Nature has created other photoresponsive systems that could
be re-engineered into light-actuated probes of patterning mech-
anisms. For example, plants control phototropism and stomatal
opening through light-sensing kinases called phototropins that
contain tandem light-oxygen-voltage (LOV) domains (Christie,
2007). When exposed to blue light, the LOV domain reacts
with its flavin mononucleotide (FMN) cofactor, generating a cys-
teinyl covalent adduct that is stable for seconds and then
reverts to the noncovalent haloprotein (Figure 3F). In the Avena
sative Phototropin1 protein, formation of this covalent interme-
diate is associated with a conformational change that disrupts
interactions between one of its LOV domains and a C-terminal
helical extension called Ja, causing the latter to unfold (Harper
et al., 2003). By conjugating the LOV-Ja polypeptide to a consti-Chemistry & Bitutively active mutant of Rac1, a GTPase that regulates actin
cytoskeletal dynamics, Hahn and coworkers were able to pro-
duce a photoactivatable Rac1 chimera (PA-Rac1) (Wu et al.,
2009). In the absence of light, the LOV-Ja polypeptide prevented
the binding of Rac1 to its downstream effector PAK, whereas
exposure to 458 nm light induced unwinding of the Ja helix,
restored Rac1-PAK interactions, and promoted lamellipodial
protrusions and membrane ruffling. PA-Rac1 photoactivation is
reversible, repeatable, and can be conducted in whole organ-
isms, as demonstrated by the Huttenlocher laboratory (Yoo
et al., 2010). In collaboration with the Hahn group, they created
transgenic zebrafish that specifically expressed the PA-Rac1
fusion protein in neutrophils, and by activating PA-Rac1 with
a spatiotemporally controlled beam of 458 nm light, they were
able to direct neutrophil migration in the transgenic embryos.
Another LOV domain-containing polypeptide, the FKF1 protein
that controls flowering in Arabidopsis thaliana, has been re-engi-
neered to achieve light-activated protein-protein interactions in
live cells. In this case, FKF1 associates with another flowering
regulator called GIGANTEA (GI) in a light-dependent manner
(Sawa et al., 2007), and the Dolmetsch laboratory has demon-
strated that fusion proteins containing these polypeptides can
photodimerize in a similar manner (Yazawa et al., 2009). For
instance, cells coexpressing FKF1-Rac1 and farnesylated GI
exhibit plasma membrane translocation of Rac1 activity upon
exposure to 450 nm light, and focal illumination can induce the
formation of lamellipodia. Dolmetsch and coworkers also achi-
eved light-activated gene transcription by fusing FKF1 to the
VP16 activation domain and GI to the Gal4 DNA-binding domain.
Unlike thePhototropin1-derivedLOV-Ja system, the light-induced
cysteinyl-flavin adduct in FKF1 persists for hours rather than
seconds. Short illumination times can therefore induce long-
lasting protein-protein interactions, making the FKF1/GI-based
approach preferable for certain research applications.
Chemical Control of Cell Function
As detailed in the sections above, our efforts to understand
embryonic patterning at the molecular level is now matched
with synthetic tools that enable perturbations of DNA, RNA, or
protein function with spatiotemporal precision. It should be
noted, however, that the surgical manipulations and ablations
that characterized embryology prior to its molecular revolution
are still valuable research tools. Genetic technologies that
enable conditional and targeted cell ablation have also been
developed, in particular methods that involve the tissue-specific
expression of a diphtheria toxin-derived polypeptide (Breitman
et al., 1987; Palmiter et al., 1987). Although this approach has
provided important insights into metazoan development and
physiology, its reliance on genomic regulatory elements limits
its generality. The precise timing and efficacy of cell ablation
are subject to the activities of these promoters, and due to the
high toxicity of this diphtheria toxin fragment, even low levels
of promoter activity can lead to unintended cell death and
embryonic mispatterning. These problems can be mitigated to
some extent by delivering full-length diphtheria toxin into trans-
genic organisms expressing the receptor for this polypeptide in
targeted tissues (Saito et al., 2001); however, the proteolytic
susceptibility of diphtheria toxin and its short biological half-life
are other potential drawbacks.ology 17, June 25, 2010 ª2010 Elsevier Ltd All rights reserved 601
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Figure 4. Chemically Induced Cell Ablation
(A) Schematic representation of metronidazole-dependent apoptosis
of nitroreductase-expressing cells (red) without collateral damage to
adjacent cells (green).
(B) Metronidazole-induced ablation of pancreatic b cells (red) in trans-
genic zebrafish larvae with insulin promoter-driven nitroreductase-
mCherry expression (ins:NTR-mCherry). Exocrinepancreas cells (green)
were not affected, and no drug-dependent cell ablation was observed
in ins:mCherry larvae. Adapted with permission (Pisharath et al., 2007;
copyright 2006, Elsevier Ireland Ltd.).
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cules could provide greater experimental flexibility, particularly
with respect to the timing, tunability, and sustainability of these
perturbations. One such method takes advantage of nitro
group-containing prodrugs, which are converted into potent
cytotoxic agents by their nitroreductase-expressing bacterial
targets (Roldan et al., 2008). The first demonstration of this
approach was conducted by Clark and his coworkers, who
generated transgenic mice that express E. coli nitroreductase
in luminal cells of the mammary gland (Clark et al., 1997). Treat-
ment of these mice with the prodrug CB1954 resulted in the
rapid apoptosis of these cells, whereas neighboring myoepithe-
lial cells were not affected. More recently, nitroreductase-medi-
ated cell ablation has been executed in zebrafish by the Parsons
and Stainier laboratories (Curado et al., 2007; Pisharath et al.,
2007). In these studies, zebrafish lines that selectively express
the bacterial enzyme in pancreatic b cells, cardiomyocytes, or
hepatocytes were generated, and the transgenic embryos were
cultured in medium containing the prodrug metronidazole at
various time points. Spatially and temporally controlled cell abla-
tion was achieved in each case, and the targeted tissues were
able to recover upon washout of the nitroreductase substrate
(Figure 4). While tissue-dependent drug penetrance and ablation
rates have been observed (Curado et al., 2007), the nitroreduc-
tase/metronidazole technique appears to be a generalizable
strategy for studying tissue patterning and regeneration.
Concluding Remarks
The examples highlighted in this review illustrate how synthetic
systems created by chemistry and protein engineering have
changed the way we study embryogenesis and other organ-
ismal processes. As we try to understand increasingly complex
systems, new approaches will be needed to interrogate
patterning mechanisms with greater experimental finesse and
spatiotemporal precision. For the immediate future, the devel-
opmental biology community would benefit from the extension
of existing technologies. Just as the ‘‘bump-and-hole’’
approach has enabled the inhibition of individual kinases with
genome-wide specificity, this method could be applied to
other gene families, particularly those that share a common
cofactor and/or structural motif. For instance, allele-specific
inhibitors of methyltransferases or acetyltransferases could602 Chemistry & Biology 17, June 25, 2010 ª2010 Elsevier Ltd All rights resprovide critical insights into the epigenetic mechanisms
that regulate cell fate. Orthogonal riboswitches could
enable simultaneous control of multiple transcripts,
and parallel ‘‘single-ligand, single-domain’’ degradation
systems could achieve the same versatility at the protein
level. Both approaches would allow biologists to deter-mine how developmental signaling molecules work in concert
to effect specific morphological changes.
There are also a number of technical challenges facing the
chemical and developmental biology communities as we seek
amoremolecular, quantitative understanding of embryogenesis.
The increasing demand for conditional reagents requires that
new caging technologies be developed. Chromophores that
are more sensitive to ultraviolet light or compatible with two-
photon irradiation would minimize cell damage and facilitate
the targeting of deeper tissues. Caging strategies for small mole-
cules or oligomers that do not involve light-sensitive groups
could also be valuable advances because not all tissues are
readily targeted with focal or patterned light sources. In these
cases, enzymatically triggered reagents could be used in
conjunction with transgenic animals, in analogy to the nitrore-
ductase-based cell ablation technology.
In addition, new methods for delivering and maintaining exog-
enous reagents in whole organisms are needed. In the case of
caged small molecules, their efficacy in vivo hinges upon their
rates of diffusion and the rates of the biological processes they
actuate. Strategies for limiting the former after uncaging would
therefore broaden the functionality of these compounds. The
membrane impermeability of synthetic oligonucleotides poses
a different challenge, as their delivery into noninjectable embryos
or at later developmental stages is a major technical hurdle.
Technologies that enable the uniform delivery of these com-
pounds into embryos, ideally by simply adding them to the
culture medium, would be a significant breakthrough.
Given the evolutionary diversity of metazoans, it is unlikely
that a single synthetic strategy will be the ‘‘silver bullet’’ for deci-
phering the dynamic mechanisms that control embryogenesis.
For optically transparent embryos that develop ex utero, tech-
nologies involving genetically encoded photoswitchable pro-
teins hold particular promise. The direct optical control of protein
function is unsurpassed for its immediate impact on develop-
mental signaling, as well as its spatiotemporal precision. The
reversibility of optogenetic systems is also unparalleled by
methods that target DNA or RNA function, as the basal state
can be restored seconds after the light source is removed.
One can even envision a suite of engineered, light-activatable
domains that survey a broad range of deactivation rates, allow-
ing one to select protein activity lifetimes that match specificerved
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properties could also be engineered to enable orthogonal control
of two or more proteins, akin to the ChR2 and NpHR systems
described above. Yet how far these approaches can be
extended to other model organisms remains to be seen. Recent
advances in fiber optic systems have enabled optogenetic
manipulations in live mice (Barretto et al., 2009; Deisseroth
et al., 2006), but applying these technologies in the womb will
be experimentally challenging. In these cases, new nonoptical,
small-molecule-actuated tools will likely have a broader impact
on developmental biology research.
Just as molecular biology complemented the dissecting nee-
dle in the 1980s, small-molecule- and synthetic protein-based
technologies are now emerging as important embryological
tools. Chemical biologists therefore have an opportunity to
play leading roles in the postgenomic era of developmental
biology. Trained in chemical principles and empowered by
chemical synthesis, we are well positioned to investigate the
thermodynamic and kinetic processes that underlie embryogen-
esis and to create new research modalities unfettered by
Nature’s bonds. Through this unique perspective, chemists
can help find new answers to the age-old question of how func-
tion begets form.ACKNOWLEDGMENTS
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